Overcoming Cancers Resistant to HER-2 Antibodies (Hardcover)

Overcoming Cancers Resistant to HER-2 Antibodies provides general updated information on the resistance of various human cancers to anti-HER2 therapeutic antibodies. The book also discusses the description of various sensitizing agents that can reverse resistance when used in combination with anti-HER2 antibodies. There have been a lot of reports in which the treatment with anti-HER2 antibodies for various cancers has resulted in clinical responses; however, there have been also subsets of cancer patients who did not respond initially, and several responding patients developed resistance following treatments. Sections cover Lapatinib, Ganetespib, Paclitaxel, Celecoxib, Emantasine, Liposomal Doxorubicin, and Kinase Inhibitors. This book is a valuable source for cancer researchers, oncologists, pharmacologists and different members of the biomedical field interested in fighting cancer resistance to HER-2 antibodies.

General

Imprint:	Academic Press Inc
Country of origin:	United States
Series:	Breaking Tolerance to Antibody-Mediated Immunotherapy
Release date:	September 2023
First published:	2024
Editors:	Benjamin Bonavida
Dimensions:	234 x 191mm (L x W)
Format:	Hardcover
Pages:	250
ISBN-13:	978-0-12-816408-2
Categories:	Books
LSN:	0-12-816408-5
Barcode:	9780128164082

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!